Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Allakos Inc (ALLK)

Allakos Inc (ALLK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Allakos Inc 825 Industrial Road Suite 500 Redwood City CA 94070 USA

P: 650-597-5002

Description:

Allakos Inc. is a clinical stage bio-technology company. It discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory and proliferative diseases. Allakos Inc. is based in CA, United States.

Key Statistics

Overview:

Market Capitalization, $K 614,321
Enterprise Value, $K 190,081
Shares Outstanding, K 85,204
Annual Sales, $ 0 K
Annual Net Income, $ -269,860 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -30,837 K
60-Month Beta 0.45
% of Insider Shareholders 33.25%
% of Institutional Shareholders 93.07%
Float, K 56,874
% Float 66.75%
Short Volume Ratio 0.37

Growth:

1-Year Return 10.24%
3-Year Return 3.40%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.53 on 11/07/22
Next Earnings Date 03/07/23
Earnings Per Share ttm -5.03
EPS Growth vs. Prev Qtr 41.11%
EPS Growth vs. Prev Year 54.31%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 10-1 on 12/22/21

ALLK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -116.74%
Return-on-Assets % -92.48%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.87
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar